View Author
receptor angiotensin effect ang ii renin heart hypertension level inhibitor study blood angiotensin ii pressure aortic blood pressure prorenin patient treatment fibulin concentration sunitinib inhibition figure tissue danser kidney change plasma expression bradykinin 2 receptors ang i blockade response aliskiren animal subject aorta ang iii conversion artery danser ahj enzyme quinaprilat ang ii levels presence system injection ang iv activation control 2 receptor aneurysm ang ii receptors fibulin -4r mice generation absence 1 receptor blockade serum mouse n-domain subtype irbesartan heart rate c-domain stimulation 2 receptor stimulation ang ii generation growth factor domain schalekamp madh baseline syndrome angiotensin iii function circulation result captopril angiogenesi
10 Most Recent Publications
|
Complex genetics of radial ray deficiencies: Screening of a cohort of 54 patients
(Article)
Vergult, S. Hoogeboom, A.J.M. Esch, J.H.M. van Kuechler, A. Barge-Schaapveld, D.Q.C.M. Sznajer, Y. Mortier, G. Menten, B. Bijlsma, E. Sante, T. Klopocki, E. Wilde, B. de Jongmans, M. Thiel, C. Verheij, J.B. Perez-Aytes, A. |
2013-03-01
|
|
Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression
(Article)
Kappers, M.H.W. Esch, J.H.M. van Visser, T.J. Smedts, F. Krijger, R.R. de Eechoute, K. Mathijssen, R.H.J. Sleijfer, S. Leijten, F.P.J. Danser, A.H.J. Meiracker, A.H. van den |
2011-10-01
|
|
Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: Effect of angiotensin II type 1 (AT1) receptor blockade
(Article)
Moltzer, E. Riet, L. te Waard, M. de Duncker, D.J.G.M. Spek, P.J. van der Rouwet, E. Danser, A.H.J. Essers, J. Swagemakers, S.M.A. Heijningen, P.M. van Vermeij, M. Veghel, R. van Bouhuizen, A.M.B. Esch, J.H.M. van Lankhorst, S. Ramnath, N.W.M. |
2011-08-12
|
|
The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system
(Article)
Kappers, M.H.W. Smedts, F. Horn, T. Esch, J.H.M. van Sleijfer, S. Leijten, F.P.J. Wesseling, S. Strevens, H. Danser, A.H.J. Meiracker, A.H. van den |
2011-08-01
|
|
The role of the renin-angiotensin system in thoracic aortic aneurysms: Clinical implications
(Article)
Moltzer, E. Essers, J. Esch, J.H.M. van Roos-Hesselink, J.W. Danser, A.H.J. |
2011-07-01
|
|
Handle region peptide counteracts the beneficial effects of the renin inhibitor aliskiren in spontaneously hypertensive rats
(Article)
Esch, J.H.M. van Veghel, R. van Garrelds, I.M. Leijten, F.P.J. Bouhuizen, A.M.B. Danser, A.H.J. |
2011-04-01
|
|
Cardiac phenotype and angiotensin II levels in AT1a, AT 1b, and AT2 receptor single, double, and triple knockouts
(Article)
Esch, J.H.M. van Gembardt, F. Walther, T. Sterner-Kock, A. Heringer-Walther, S. Le, T.H. Laßner, D. Stijnen, Th. Coffman, T.M. Schultheiss, H.P. Danser, A.H.J. |
2010-06-01
|
|
Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat loss of angiotensin II type 2 receptor-mediated vasodilation
(Article)
Moltzer, E. Verkuil, A.V.A. Veghel, R. van Danser, A.H.J. Esch, J.H.M. van |
2010-02-01
|
|
Cardiovascular and renal toxicity during angiogenesis inhibition: Clinical and mechanistic aspects
(Article)
Kappers, M.H.W. Esch, J.H.M. van Sleijfer, S. Danser, A.H.J. Meiracker, A.H. van den |
2009-12-01
|
|
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors
(Article)
Gembardt, F. Heringer-Walther, S. Walther, T. Esch, J.H.M. van Sterner-Kock, A. Veghel, R. van Le, T.H. Garrelds, I.M. Coffman, T.M. Danser, A.H.J. Schultheiss, H.P. |
2008-08-01
|
